This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Rosacea

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is a skin disorder where there is fixed or recurrent erythema, telangiectasia, oedema, papules and pustules affecting the forehead, cheeks, nose and often the chin.

It is most often seen in people with fair skin that burns easily but can also occur in people of African descent (1)

It is relatively common, with a female prevalence of 5% and a male prevalence of just under 4% for men (2) but men are more likely to progress to severe disease (2).

The onset is typically between the ages of 30 and 60. (3)

Ocular changes are the initial presentation in 20% of patients (4)

Click here for an example image of this condition

Reference:

1. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018 Jan;78(1):148-55.

2. Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018 Aug;179(2):282-9.

3. Two AM, Wu W, Gallo RL, et al. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015 May;72(5):749-58.

4. Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020 Jun;82(6):1501-10.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.